Regulatory actions for Aug. 7, 2026

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Co-Diagnostics, Galibra, Genesis, Medtronic, Merck, Mirum, Moderna, Takeda.